SEER (Seer, Inc.) Stock Financials & Earnings | Market Cap Arena

SEER (Seer, Inc.) Stock Financials & Earnings | Market Cap Arena

SEERSeer, Inc.

Mkt Cap$101M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$17M

Net Income (TTM)-$74M

EPS (TTM)-$1.28

Free Cash Flow (TTM)-$46M

Gross Margin51.1%

Op. Margin-470.5%

Net Margin-444.0%

FCF Margin-279.0%

P/S Ratio (TTM)6.1x

P/E Ratio (TTM)—

YoY Rev Growth+18.2%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$4M	$762K	-$27M
Q2 23	$4M	$923K	-$28M
Q3 23	$4M	$658K	-$26M
Q4 23	$4M	$2M	-$22M
Q1 24	$3M	-$133K	-$25M
Q2 24	$3M	$229K	-$27M
Q3 24	$4M	$2M	-$24M
Q4 24	$4M	$366K	-$24M
Q1 25	$4M	$2M	-$21M
Q2 25	$4M	$2M	-$21M
Q3 25	$4M	$2M	-$19M
Q4 25	$4M	$2M	-$17M

Valuation

Quarter	P/S	P/E
Q1 23	6.5x	—
Q2 23	6.4x	—
Q3 23	6.3x	—
Q4 23	6.2x	—
Q1 24	6.6x	—
Q2 24	7.0x	—
Q3 24	7.1x	—
Q4 24	7.2x	—
Q1 25	6.7x	—
Q2 25	6.3x	—
Q3 25	6.2x	—
Q4 25	6.1x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$19M	-$19M
Q2 23	-$15M	-$16M
Q3 23	-$14M	-$19M
Q4 23	-$10M	-$12M
Q1 24	-$10M	-$11M
Q2 24	-$10M	-$11M
Q3 24	-$14M	-$16M
Q4 24	-$11M	-$11M
Q1 25	-$11M	-$12M
Q2 25	-$15M	-$15M
Q3 25	-$8M	-$8M
Q4 25	-$11M	-$11M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$121K
Q2 23	$1M
Q3 23	$4M
Q4 23	$2M
Q1 24	$754K
Q2 24	$1M
Q3 24	$2M
Q4 24	$536K
Q1 25	$654K
Q2 25	$568K
Q3 25	$283K
Q4 25	$292K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+22.4%	+16.2%
Q2 23	+10.7%	+18.1%
Q3 23	+5.2%	+3.4%
Q4 23	+8.3%	-8.3%
Q1 24	-24.4%	-10.3%
Q2 24	-23.4%	-5.6%
Q3 24	-5.3%	-5.8%
Q4 24	-5.5%	+4.1%
Q1 25	+37.1%	-11.8%
Q2 25	+31.9%	-18.5%
Q3 25	+4.5%	-17.0%
Q4 25	+6.4%	-21.5%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$0	0.0%
Q2 23	$0	0.0%
Q3 23	$8M	200.2%
Q4 23	$8M	182.2%
Q1 24	$8M	247.2%
Q2 24	$8M	249.5%
Q3 24	$7M	165.5%
Q4 24	$6M	163.1%
Q1 25	$5M	110.9%
Q2 25	$4M	95.6%
Q3 25	$4M	87.2%
Q4 25	$3M	78.2%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	$13M	$15M
Q2 23	$13M	$16M
Q3 23	$12M	$15M
Q4 23	$11M	$13M
Q1 24	$11M	$14M
Q2 24	$11M	$16M
Q3 24	$13M	$13M
Q4 24	$11M	$13M
Q1 25	$11M	$11M
Q2 25	$12M	$11M
Q3 25	$11M	$11M
Q4 25	$10M	$10M

Revenue Segments

Quarter	Grant and Other	Product	Related Party	Service
Q1 23	$335K	$2M	$1M	$69K

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$48M	$304M	$352M
Q2 23	$56M	$264M	$320M
Q3 23	$36M	$295M	$331M
Q4 23	$32M	$284M	$316M
Q1 24	$54M	$254M	$309M
Q2 24	$32M	$252M	$283M
Q3 24	$38M	$210M	$248M
Q4 24	$41M	$196M	$236M
Q1 25	$52M	$187M	$240M
Q2 25	$38M	$172M	$210M
Q3 25	$45M	$154M	$199M
Q4 25	$47M	$139M	$186M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	64M	+1.2%
Q2 23	64M	+0.3%
Q3 23	64M	+0.3%
Q4 23	64M	+0.4%
Q1 24	65M	+0.7%
Q2 24	65M	-0.0%
Q3 24	61M	-5.2%
Q4 24	61M	+0.0%
Q1 25	59M	-2.9%
Q2 25	58M	-2.2%
Q3 25	56M	-3.1%
Q4 25	57M	+2.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 18	—	—
FY 19	—	—
FY 20	$11K	60
FY 21	$54K	118
FY 22	$90K	164
FY 23	$103K	147
FY 24	$43K	325
FY 25	$9K	2K